UnknownNot Applicable

Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms

Egypt165 participantsStarted 2019-12-20

Plain-language summary

To assess the clinical risk factors and predictable biomarkers of thrombotic complications in cases of philadelphia negative myeloproliferative disorders.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: age \> 18 years All patients diagnosed as BCR-ABL negative myeloproliferative neoplasm e.g: Polycythemia vera Essential thrombocythemia Primary myelofibrosis Exclusion Criteria: * BCR- ABL positive MPN e.g CML * Secondary erythrocytosis. * Secondary thrombocytosis. * Secondary bone marrow fibrosis.

What they're measuring

Incidence of thromboembolic events in Philadelphia negative myeloproliferative neoplasms

Timeframe: 3 years

Trial details

NCT IDNCT03599700

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

Contact for this trial

maha mohammed

01097278659 maha.azez@yahoo.com

View on ClinicalTrials.gov More Thrombosis trials